从患有法布里病的患者产生诱导多能干细胞系 (SMBCi022-A)
Zihan Li1, Jing Luan1, Yali Yang1
1Department of Orthopedic Surgery, The First Affiliated Hospital of Shandong First Medical University, Ji'nan 250014 Shandong, China; Biomedical Sciences College, Shandong Medicinal Biotechnology Centre, Shandong First Medical University& Shandong Academy of Medical Sciences, Ji'nan 250062 Shandong, China; Key Lab for Biotech-Drugs of National Health Commission, Ji'nan 250062 Shandong, China; Key Lab for Rare & Uncommon Diseases of Shandong Province, Ji'nan 250062 Shandong, China.
Stem cell research
|January 26, 2025
概括
诱导多能干细胞 (iPSC) 是从具有特定GLA突变的法布里病患者中制造出来的. 这些经过验证的iPSC为研究法布里病的进展和开发新治疗方法提供了有价值的模型.
科学领域:
- 遗传学和再生医学的研究
- 罕见疾病研究 罕见疾病研究
- 干细胞生物学 干细胞生物学
背景情况:
- 法布里病 (FD) 是一种遗传性疾病,由α-银酸酶A (GLA) 基因的突变引起.
- 这导致球体基胺和其他葡萄糖脂在组织中的积累.
- 目前的治疗方法旨在控制症状,但治疗开发需要疾病特异性的细胞模型.
研究的目的:
- 为了产生和验证诱导多能干细胞 (iPSCs) 从一个法布里病患者.
- 为研究法布里病的病理生理学建立一个细胞模型.
- 为Fabry病的临床前药物发现和开发提供资源.
主要方法:
- 从已知GLA突变的10岁男性患者的尿液衍生细胞生成iPSCs (c.1080_1082del).
- 通过评估多能性标记物,三线化分化潜力和型,对iPSC的验证.
- 在iPSC系列中确认了针对的法布里病突变.
主要成果:
- 成功生成并表征携带GLA突变的患者特异性iPSCs.
- 确认了多能性,分化能力,正常型,以及在iPSC中存在特定突变.
- 为法布里病研究建立了一个可靠的细胞模型.
结论:
- 生成的iPSCs代表了理解法布里病机制的宝贵工具.
- 这种细胞模型有助于评估疾病进展和测试潜在的治疗干预措施.
- 这些iPSC是开发新药治疗法布里病的关键资源.
相关概念视频
Induced Pluripotent Stem Cells
21.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
21.9K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K


